Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - GoodwillCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares Issued
Ratios

Legend Biotech (LEGN) Other Gross PP&E Adjustments (2019 - 2025)

Legend Biotech filings provide 7 years of Other Gross PP&E Adjustments readings, the most recent being -$285.2 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 179.88% to -$285.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$285.2 million, a 179.88% decrease, with the full-year FY2025 number at -$285.2 million, down 179.88% from a year prior.
  • Other Gross PP&E Adjustments hit -$285.2 million in Q4 2025 for Legend Biotech, down from -$142.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$7547.0 in Q1 2021 to a low of -$285.2 million in Q4 2025.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$80.3 million (2023), compared with a mean of -$84.5 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: rose 8.08% in 2021 and later crashed 526877.61% in 2022.
  • Legend Biotech's Other Gross PP&E Adjustments stood at -$38.3 million in 2021, then tumbled by 45.21% to -$55.6 million in 2022, then plummeted by 44.81% to -$80.5 million in 2023, then decreased by 26.58% to -$101.9 million in 2024, then crashed by 179.88% to -$285.2 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were -$285.2 million (Q4 2025), -$142.3 million (Q3 2025), and -$127.2 million (Q2 2025) per Business Quant data.